Acquired Company

BioVaxys completed the acquisition of IMV Inc.'s assets and intellectual property on 2/21/2024, acquiring the former IMV portfolio via an asset purchase in a transaction completed with BioVaxys Technology Corp. as the acquirer.

Show more

Pharmaceutical Preparation Manufacturing

Manufacturing

Start AI Chat

Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$N/A

Open

$N/A

Volume

N/A

Day Range

$N/A - $N/A

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

0.41%

Institutional Own.

20.37%

Qtr Updated

03/31/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Maveropepimut-S (DPX-Survivac) (Survivin) + CPA Details Ovarian cancer, Cancer	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Maveropepimut-S (DPX-Survivac) (Survivin) + Keytruda + CPA Details Diffuse large B cell lymphoma, Cancer	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Maveropepimut-S (DPX-Survivac) (Survivin) + CPA + Pemrolizumab Details Cancer, Ovarian cancer	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Maveropepimut-S (DPX-Survivac) (Survivin) Details Cancer, Solid tumor/s, Breast cancer	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DPX-COVID-19 Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DPX-RSV Details Respiratory syncytial virus	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Maveropepimut-S (DPX-Survivac) (Survivin) + CPA + Keytruda Details Ovarian cancer, Bladder cancer, Liver cancer, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.